Nutra Pharma Corp.
NPHC
$0.00
$0.000.00%
OTC PK
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | 12.71% | 0.25% | 52.89% | -118.34% | 459.94% |
| Total Depreciation and Amortization | -12.80% | 1.63% | 1.65% | -50.61% | 128.97% |
| Total Amortization of Deferred Charges | -19.49% | -9.93% | -52.29% | -52.37% | -2.99% |
| Total Other Non-Cash Items | 50.18% | -24.18% | -76.53% | 103.60% | -320.58% |
| Change in Net Operating Assets | -125.13% | 14,175.00% | -99.69% | -71.16% | 560.13% |
| Cash from Operations | -121.14% | 54.93% | -101.29% | -71.85% | 67.33% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -100.00% | 441.84% | -198.00% | -80.58% | 6.63% |
| Cash from Investing | 149.55% | 441.84% | -198.00% | -80.58% | 6.63% |
| Total Debt Issued | -13.68% | -16.87% | 36.27% | -33.31% | 18.65% |
| Total Debt Repaid | 46.46% | -123.82% | 33.39% | 60.16% | -101.20% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 102.37% | -74.22% | 137.56% | 3,212.00% | -97.65% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -- | -- | -- | 100.00% |